These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32321351)

  • 1. Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study.
    Weidmann H; Bannasch JH; Waldeyer C; Shrivastava A; Appelbaum S; Ojeda-Echevarria FM; Schnabel R; Lackner KJ; Blankenberg S; Zeller T; Karakas M
    J Am Heart Assoc; 2020 May; 9(9):e015480. PubMed ID: 32321351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease-First Report on the Prospective Relevance of Intrinsic Iron Release.
    Ruhe J; Waldeyer C; Ojeda F; Altay A; Schnabel RB; Schäfer S; Lackner KJ; Blankenberg S; Zeller T; Karakas M
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30096922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
    Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
    J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Iron-Homeostasis Regulating Peptide Hepcidin in Coronary Heart Disease-Evidence from the Large AtheroGene Study.
    Zeller T; Altay A; Waldeyer C; Appelbaum S; Ojeda F; Ruhe J; Schnabel RB; Lackner KJ; Blankenberg S; Karakas M
    Biomolecules; 2018 Jun; 8(3):. PubMed ID: 29958400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations.
    Braun S; Ndrepepa G; von Beckerath N; Vogt W; Schömig A; Kastrati A
    Atherosclerosis; 2004 May; 174(1):105-10. PubMed ID: 15135258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron status and clinical outcome in patients with coronary artery disease after coronary stenting.
    Ndrepepa G; Braun S; Dibra A; Mehilli J; Vogt W; Schömig A; Kastrati A
    Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):418-25. PubMed ID: 16314228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin, iron metabolism and angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study).
    Grammer TB; Kleber ME; Silbernagel G; Pilz S; Scharnagl H; Tomaschitz A; König W; März W
    Atherosclerosis; 2014 Oct; 236(2):292-300. PubMed ID: 25112800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.
    Ghasemzedah N; Hayek SS; Ko YA; Eapen DJ; Patel RS; Manocha P; Al Kassem H; Khayata M; Veledar E; Kremastinos D; Thorball CW; Pielak T; Sikora S; Zafari AM; Lerakis S; Sperling L; Vaccarino V; Epstein SE; Quyyumi AA
    Circ Cardiovasc Qual Outcomes; 2017 Mar; 10(3):. PubMed ID: 28280039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
    Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
    PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome.
    Zeller T; Waldeyer C; Ojeda F; Schnabel RB; Schäfer S; Altay A; Lackner KJ; Anker SD; Westermann D; Blankenberg S; Karakas M
    Biomolecules; 2018 Jul; 8(3):. PubMed ID: 30037035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble transferrin receptor and risk of type 2 diabetes in the obese and nonobese.
    Fernández-Cao JC; Arija V; Aranda N; Basora J; Diez-Espino J; Estruch R; Fitó M; Corella D; Salas-Salvadó J
    Eur J Clin Invest; 2017 Mar; 47(3):221-230. PubMed ID: 28075490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron status and survival in diabetic patients with coronary artery disease.
    Ponikowska B; Suchocki T; Paleczny B; Olesinska M; Powierza S; Borodulin-Nadzieja L; Reczuch K; von Haehling S; Doehner W; Anker SD; Cleland JG; Jankowska EA
    Diabetes Care; 2013 Dec; 36(12):4147-56. PubMed ID: 24130349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease.
    Kotecha D; Flather MD; Atar D; Collins P; Pepper J; Jenkins E; Reid CM; Eccleston D;
    BMC Med; 2019 Apr; 17(1):72. PubMed ID: 30943979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
    Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
    Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease.
    Muhlestein JB; May HT; Bair TL; Prescott MF; Horne BD; White R; Anderson JL
    Am J Cardiol; 2010 Sep; 106(6):764-9. PubMed ID: 20816114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.
    Koskinas KC; Ndrepepa G; Räber L; Karagiannis A; Kufner S; Zanchin T; Hieber J; Hunziker L; Mayer K; Byrne RA; Heg D; Windecker S; Kastrati A
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e006752. PubMed ID: 30545257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
    Tang WH; Iqbal N; Wu Y; Hazen SL
    Am J Cardiol; 2013 Feb; 111(4):465-70. PubMed ID: 23219176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.